Moreover, based on the LSCC RNA sequencing data from the TCGA database, the expression levels of Hh pathway-related positive components (including SMO, GLI1, and GLI2) in LSCC tumor tissues were significantly higher than those in normal lung tissues (Figure 3), reflecting the LSCC characteristic of Hh pathway activation. The gene discussed is SMO; the disease is neoplasm.